Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Romero-Vigara

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Semergen|December 5, 2023
[Current situation of direct oral anticoagulants in primary care in Spain: Positioning of SEMERGEN in 2023]J Polo-García, V Pallares-Carratalá, M Turegano-Yedro, et al.
Semergen|February 11, 2026
Oral anticoagulation in patients with atrial fibrillation in Primary Care in Spain. Rationale, design and baseline data of the RACOVIR studyJ Polo-García, R M Micó-Pérez, E García-Gabriel, et al.
Semergen|December 14, 2018
[Clinical and socio-sanitary characteristics in adults older than 65 years attended in the Primary Care setting. The PYCAF study]J C Romero Vigara, J L Llisterri Caro, M Turégano Yedro, et al.
Semergen|August 13, 2019
[Risk of falls and drug use in patients over 65 years of age. The PYCAF study]M Turégano Yedro, A Núñez Villén, J C Romero Vigara, et al.
Semergen|February 19, 2022
Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping reviewA Ruiz-García, V Pallarés-Carratalá, A Serrano-Cumplido, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Semergen|December 5, 2023
[Current situation of direct oral anticoagulants in primary care in Spain: Positioning of SEMERGEN in 2023]J Polo-García, V Pallares-Carratalá, M Turegano-Yedro, et al.
Semergen|February 11, 2026
Oral anticoagulation in patients with atrial fibrillation in Primary Care in Spain. Rationale, design and baseline data of the RACOVIR studyJ Polo-García, R M Micó-Pérez, E García-Gabriel, et al.
Semergen|December 14, 2018
[Clinical and socio-sanitary characteristics in adults older than 65 years attended in the Primary Care setting. The PYCAF study]J C Romero Vigara, J L Llisterri Caro, M Turégano Yedro, et al.
Semergen|August 13, 2019
[Risk of falls and drug use in patients over 65 years of age. The PYCAF study]M Turégano Yedro, A Núñez Villén, J C Romero Vigara, et al.
Semergen|February 19, 2022
Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping reviewA Ruiz-García, V Pallarés-Carratalá, A Serrano-Cumplido, et al.
Pageof 1